Author Archive: George Goodno

George Goodno

George is the Director of State Policy Communications at BIO and enjoys the opportunity to advocate for and educate audiences about the positive societal and economic impact of the bioscience industry. Another great aspect of his job is getting to work with BIO’s broad network of state bioscience associations to help advance legislative and regulatory initiatives that will continue to improve this high-skill, high-wage industry. In his spare time, he enjoys running, skiing, hiking, gardening, and most of all, spending time with his awesome wife and two daughters.

Follow him on Twitter @ggoodno

 

Latest Posts

California Continues Responsible Support for Interchangeability of Biologic Drugs

State Capitol

Yesterday, California’s State Assembly Committee on Appropriations took another decisive step when they unanimously voted in support of the revised SB 598 by recommending it back to the full Assembly after minor modifications. This is another important step taken by the California State Legislature to ensure patients and physicians who are managing chronic conditions are made fully aware of which biologic drug is ultimately administered by the pharmacist. When battling a serious disease, patients, physicians Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,

FDA Issues Final Guidance on Clinical Trial Oversight

admin-ajax

The FDA released its final guidance governing clinical trial oversight and urges a risk-based approach to monitoring. The Agency builds on the main tenets described in the original 2011 draft guidance, urging drug and medical-device sponsors to utilize more remote and targeted risk-based monitoring rather than relying solely on on-site methods. The guidance provides various risk-based monitoring strategies and clarifies that while the Sponsor can transfer monitoring responsibilities to contract research organizations (CROs), the CROs Read More >

Health  |  Leave a comment  |  Email This Post
Tags: ,

How Do Patients Get Their Medicines During Hurricanes?

hurricane-season-hurricane-earl-2010-1024x576-940x198

Hurricane season has grown to last six months – running June through November. This means we are well into 2013′s hurricane season. Although the Eastern and Southern United States have seen their fair share of bad storms in the last few years, the most recent major hurricane to strike the U.S. was Hurricane Wilma in 2005. Surprisingly Hurricane Sandy in October of 2012 was not technically was not a hurricane, but a confluence of major Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , ,

BioOhio Selects New Leadership

lewis-john250

John Lewis has been promoted to CEO of BioOhio, the biological sciences trade organization, recognized as BIO’s affiliated state organization in Ohio. John has been with BioOhio for the last twelve years and has been instrumental to its highly successful efforts to grow the biotech industry in the state. Earlier this year, BioOhio’s previous long-serving head, Tony Dennis, retired. Under Tony’s 11-year leadership, BioOhio helped elevate Ohio into top-tier ranks amongst virtually all bioscience industry Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: ,

Small Biotechs in California Save Big on Health Insurance Rates

San Francisco skyline

There are many reasons companies decide to join trade associations. Whether it’s a long-term legislative advocacy priority, increased access to networking events or group-savings programs, the decision ultimately comes down to a company’s financial bottom line. BayBio and BIOCOM, two California-based biotech trade groups, both of whom are affiliated with BIO, came together during the low point of the most recent recession, to establish a fund that created a healthcare insurance pool accessible by the Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: ,